Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,714 | 1,537 | 78.2% |
| Consulting Fee | $6,210 | 4 | 17.5% |
| Travel and Lodging | $1,353 | 4 | 3.8% |
| Education | $142.37 | 19 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $7,205 | 108 | $0 (2024) |
| Allergan, Inc. | $2,978 | 41 | $0 (2020) |
| ABBVIE INC. | $2,620 | 122 | $0 (2024) |
| Novo Nordisk Inc | $2,485 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,129 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,922 | 99 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,784 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,587 | 117 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,315 | 71 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,256 | 97 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,242 | 146 | AstraZeneca Pharmaceuticals LP ($454.46) |
| 2023 | $5,113 | 176 | PFIZER INC. ($1,362) |
| 2022 | $3,811 | 191 | ABBVIE INC. ($500.44) |
| 2021 | $3,872 | 210 | AbbVie Inc. ($703.81) |
| 2020 | $2,340 | 151 | AstraZeneca Pharmaceuticals LP ($415.59) |
| 2019 | $7,777 | 236 | PFIZER INC. ($4,429) |
| 2018 | $3,376 | 204 | Novo Nordisk Inc ($437.06) |
| 2017 | $5,890 | 250 | Allergan Inc. ($2,450) |
All Payment Transactions
1,564 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Cranial Orthotic | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,055 | 1,603 | $229,763 | $126,663 |
| 2022 | 15 | 1,142 | 1,977 | $252,429 | $137,616 |
| 2021 | 18 | 1,099 | 1,924 | $233,272 | $125,309 |
| 2020 | 20 | 1,294 | 2,136 | $245,980 | $115,894 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 316 | 757 | $98,410 | $49,042 | 49.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 229 | 229 | $54,960 | $30,649 | 55.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 108 | $19,980 | $10,919 | 54.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 102 | 104 | $7,280 | $7,134 | 98.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $11,325 | $7,034 | 62.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 97 | $11,834 | $6,389 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 117 | 119 | $4,165 | $3,846 | 92.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 34 | $7,650 | $3,700 | 48.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $4,500 | $3,099 | 68.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 26 | $4,420 | $2,478 | 56.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 36 | $1,080 | $1,058 | 98.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 16 | 17 | $2,125 | $955.91 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $1,554 | $243.40 | 15.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 12 | $480.00 | $115.83 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 337 | 833 | $108,290 | $54,633 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 186 | 186 | $44,640 | $25,567 | 57.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 207 | $25,254 | $12,369 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 115 | $21,275 | $11,717 | 55.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 119 | 120 | $8,385 | $8,213 | 97.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 43 | 69 | $15,525 | $7,639 | 49.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 42 | 62 | $10,540 | $5,397 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 126 | 127 | $4,445 | $3,942 | 88.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 29 | 29 | $3,625 | $3,584 | 98.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,750 | $1,945 | 70.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 35 | 35 | $1,050 | $1,037 | 98.8% |
About Dr. Daniel Chen, DO
Dr. Daniel Chen, DO is a Family Medicine healthcare provider based in La Grange Highlands, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356355812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Chen, DO has received a total of $35,420 in payments from pharmaceutical and medical device companies, with $3,242 received in 2024. These payments were reported across 1,564 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($27,714).
As a Medicare-enrolled provider, Chen has provided services to 4,590 Medicare beneficiaries, totaling 7,640 services with total Medicare billing of $505,482. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location La Grange Highlands, IL
- Active Since 07/28/2006
- Last Updated 06/16/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356355812
Products in Payments
- BOTOX (Biological) $2,427
- ELIQUIS (Drug) $1,633
- VRAYLAR (Drug) $1,590
- XARELTO (Drug) $1,419
- FARXIGA (Drug) $1,135
- TRADJENTA (Drug) $1,079
- UBRELVY (Drug) $725.47
- TRELEGY ELLIPTA (Drug) $693.00
- Ozempic (Drug) $654.70
- JARDIANCE (Drug) $580.43
- JANUVIA (Drug) $540.45
- ENTRESTO (Drug) $528.57
- NURTEC ODT (Drug) $490.28
- Aimovig (Biological) $452.27
- CHANTIX (Drug) $407.23
- Vascepa (Drug) $381.66
- XIFAXAN (Drug) $379.65
- SYMBICORT (Drug) $370.30
- LYRICA (Drug) $365.19
- Trintellix (Drug) $347.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in La Grange Highlands
Mr. Scott Robertson, Do, DO
Family Medicine — Payments: $22,311
Dr. Michael Dupont, Md, MD
Family Medicine — Payments: $17,604
Samuel Traverso, Do, DO
Family Medicine — Payments: $5,882
Saba Osmani, Md, MD
Family Medicine — Payments: $340.69
Tumendemberel Byambaa, Md, MD
Family Medicine — Payments: $19.76
Mr. Chimanbhai Patel, Md, MD
Family Medicine